美国早产儿视网膜病变治疗趋势：2003 年至 2020 年。
Retinopathy of Prematurity Treatment Trends from 2003 to 2020 in the United States.
机构信息
Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; Department of Ophthalmology, Dong-A University College of Medicine, Busan, Republic of Korea.
出版信息
Ophthalmology. 2022 Oct;129(10):1216-1218. doi: 10.1016/j.ophtha.2022.06.008. Epub 2022 Jun 15.
Abstract
We used population-based data obtained from Optum’s Clinformatics® Data Mart Database to characterize recent trends in retinopathy of prematurity (ROP) treatments and outcomes in the United States. Laser photocoagulation was utilized more frequently every year compared to anti-VEGF.
摘要
我们使用来自 Optum 的 Clinformatics® Data Mart Database 的基于人群的数据，来描述美国早产儿视网膜病变（ROP）治疗和结局的最新趋势。与抗血管内皮生长因子药物相比，激光光凝的使用频率逐年增加。
相似文献
1
Retinopathy of Prematurity Treatment Trends from 2003 to 2020 in the United States.美国早产儿视网膜病变治疗趋势：2003 年至 2020 年。
Ophthalmology. 2022 Oct;129(10):1216-1218. doi: 10.1016/j.ophtha.2022.06.008. Epub 2022 Jun 15.
2
The time and financial ramifications of providing services for retinopathy of prematurity at a single inner-city institution in the United States: a pilot study.在美国一个市中心机构为早产儿视网膜病变提供服务的时间和财务影响：一项试点研究。
J AAPOS. 2022 Oct;26(5):281. doi: 10.1016/j.jaapos.2022.05.018. Epub 2022 Sep 17.
3
Retinopathy of prematurity.早产儿视网膜病变。
Pediatr Clin North Am. 2014 Jun;61(3):567-77. doi: 10.1016/j.pcl.2014.03.003. Epub 2014 Mar 26.
4
The relationship of the subtypes of preterm birth with retinopathy of prematurity.早产亚型与早产儿视网膜病变的关系。
Am J Obstet Gynecol. 2017 Sep;217(3):354.e1-354.e8. doi: 10.1016/j.ajog.2017.05.029. Epub 2017 May 22.
5
[Incidence and evolution of retinopathy of prematurity. A six year experience in a neonatal intensive care unit].[早产儿视网膜病变的发病率及演变。新生儿重症监护病房的六年经验]
Minerva Pediatr. 1992 Nov;44(11):519-23.
6
Incidence and Early Course of Retinopathy of Prematurity.早产儿视网膜病变的发生率和早期病程。
Ophthalmology. 2020 Apr;127(4S):S84-S96. doi: 10.1016/j.ophtha.2020.01.034.
7
Retinopathy of prematurity in Kenya: prevalence and risk factors in a hospital with advanced neonatal care.肯尼亚早产儿视网膜病变：一家具备先进新生儿护理条件医院的患病率及危险因素
Pan Afr Med J. 2018 Mar 15;29:152. doi: 10.11604/pamj.2018.29.152.14046. eCollection 2018.
8
[Retinopathy of prematurity: a new score for the evaluation of prematurity of infants (I)--prematurity score P].早产儿视网膜病变：一种评估婴儿早产情况的新评分方法（I）——早产评分P
Nippon Ganka Gakkai Zasshi. 1983 Mar 10;87(3):205-8.
9
Retinopathy of prematurity prevention, screening and treatment programmes: The role of neonatal networks.早产儿视网膜病变预防、筛查和治疗计划：新生儿网络的作用。
Semin Perinatol. 2019 Oct;43(6):341-343. doi: 10.1053/j.semperi.2019.05.005. Epub 2019 May 11.
10
Retinopathy of prematurity in a Danish county. Trends over the 12-year period 1982-93.丹麦某郡的早产儿视网膜病变。1982 - 1993年这12年间的趋势。
Acta Ophthalmol Scand. 1996 Jun;74(3):285-7. doi: 10.1111/j.1600-0420.1996.tb00093.x.
引用本文的文献
1
Are the Risk Factors for Bronchopulmonary Dysplasia and Retinopathy of Prematurity in Very Low-Birth-Weight Infants the Same?极低出生体重儿支气管肺发育不良和早产儿视网膜病变的危险因素相同吗？
Children (Basel). 2025 Apr 15;12(4):509. doi: 10.3390/children12040509.
2
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.雷珠单抗与激光疗法治疗极低出生体重早产儿视网膜病变（RAINBOW）：一项随机试验的五年结果
EClinicalMedicine. 2024 Apr 11;71:102567. doi: 10.1016/j.eclinm.2024.102567. eCollection 2024 May.
3
Twelve-year outcomes of bedside laser photocoagulation for severe retinopathy of prematurity.床边激光光凝治疗重度早产儿视网膜病变的12年随访结果
Front Pediatr. 2023 Jun 23;11:1189236. doi: 10.3389/fped.2023.1189236. eCollection 2023.
4
Modifiable Risk Factors and Preventative Strategies for Severe Retinopathy of Prematurity.早产儿严重视网膜病变的可改变风险因素及预防策略
Life (Basel). 2023 Apr 24;13(5):1075. doi: 10.3390/life13051075.
5
Causes of Childhood Blindness in the United States Using the IRIS® Registry (Intelligent Research in Sight).美国儿童失明的病因研究——IRIS® 注册研究（智能视觉研究）。
Ophthalmology. 2023 Sep;130(9):907-913. doi: 10.1016/j.ophtha.2023.04.004. Epub 2023 Apr 8.
6
Identification of clinical factors associated with timing and duration of spontaneous regression of retinopathy of prematurity not requiring treatment.识别与早产儿视网膜病变（ROP）自发消退的时间和持续时间相关的临床因素，这些ROP 无需治疗。
J Perinatol. 2023 Jun;43(6):702-708. doi: 10.1038/s41372-023-01649-w. Epub 2023 Mar 27.
本文引用的文献
1
Trends in Retinopathy of Prematurity Screening and Treatment: 2008-2018.早产儿视网膜病变筛查与治疗的趋势：2008 - 2018年
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-039966. Epub 2021 May 11.
2
Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database.使用商业索赔数据库比较抗 VEGF 注射与激光治疗 ROP 的两年结果。
Ophthalmic Surg Lasers Imaging Retina. 2020 Sep 1;51(9):486-493. doi: 10.3928/23258160-20200831-02.
3
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.雷珠单抗与激光治疗用于治疗极低出生体重早产儿视网膜病变（RAINBOW）：一项开放标签随机对照试验。
Lancet. 2019 Oct 26;394(10208):1551-1559. doi: 10.1016/S0140-6736(19)31344-3. Epub 2019 Sep 12.
4
The Epidemiology of Retinopathy of Prematurity in the United States.美国早产儿视网膜病变的流行病学
Ophthalmic Surg Lasers Imaging Retina. 2017 Jul 1;48(7):553-562. doi: 10.3928/23258160-20170630-06.
5
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.玻璃体内注射贝伐单抗与激光治疗 1 型早产儿视网膜病变：荧光血管造影结果报告。
Ophthalmology. 2014 Nov;121(11):2212-9. doi: 10.1016/j.ophtha.2014.05.015. Epub 2014 Jul 4.
6
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.玻璃体内注射贝伐单抗治疗 3 期及以上早产儿视网膜病变的疗效。
N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374.
7
Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.早产儿视网膜病变早期治疗（ETROP）随机试验的最终结果。
Trans Am Ophthalmol Soc. 2004;102:233-48; discussion 248-50.
Zotero 插件